NERV (STOCKS)
Minerva Neurosciences, Inc
$4.390000
-0.120000 (-2.66%)
Prev close: $4.510000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Rémy Henri Luthringer
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $204.29M
- Employees
- 8
- P/E (TTM)
- -0.15
- P/B (TTM)
- -0.76
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
3
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.17 | $-0.13 | -0.0408 | -31.58% |
|
Dec 2025 (Q4)
|
$-0.64 | $-0.31 | -0.3340 | -109.15% |
|
Jun 2025 (Q2)
|
$-0.43 | $-0.92 | +0.4880 | +53.16% |
|
Mar 2025 (Q1)
|
$-0.50 | $-1.09 | +0.5914 | +54.19% |
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $27.87M |
| Research and Development | $9.65M |
| Other Operating Expenses | $18.22M |
| Operating Income/Loss | -$27.87M |
| Income/Loss From Continuing Operations After Tax | -$415.07M |
| Income/Loss From Continuing Operations Before Tax | -$415.07M |
| Net Income/Loss | -$415.07M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$415.07M |
| Net Income/Loss Available To Common Stockholders, Basic | -$415.07M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$37.03 |
| Diluted Earnings Per Share | -$37.03 |
| Basic Average Shares | 59,932,988 |
| Diluted Average Shares | 59,932,988 |
| Assets | $94.03M |
| Current Assets | $79.11M |
| Prepaid Expenses | $941.88K |
| Other Current Assets | $78.16M |
| Noncurrent Assets | $14.92M |
| Liabilities | $343.08M |
| Current Liabilities | $4.48M |
| Accounts Payable | $2.12M |
| Other Current Liabilities | $2.36M |
| Noncurrent Liabilities | $338.60M |
| Equity | -$254.01M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$254.01M |
| Liabilities And Equity | $94.03M |
| Net Cash Flow From Operating Activities | -$14.87M |
| Net Cash Flow From Operating Activities, Continuing | -$14.87M |
| Net Cash Flow From Investing Activities | -$106.23M |
| Net Cash Flow From Financing Activities | $75.53M |
| Net Cash Flow | -$45.57M |
| Net Cash Flow, Continuing | -$45.57M |
| Comprehensive Income/Loss | -$415.07M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$415.07M |
| Other Comprehensive Income/Loss | $0.00 |